Click a link below to view the mailing archive as if it had been sent to you.
| 2016-04-30 12:15 | | AstraZeneca, Pfizer Said Among Firms Weighing Medivation Bid and more... |
| 2016-04-30 00:15 | | New Express Scripts program aims to react faster to spikes in drug prices and more... |
| 2016-04-29 12:15 | | Biogen, AbbVie multiple sclerosis drug wins EU green light and more... |
| 2016-04-29 00:15 | | Biotech Boom May Continue Through Earnings Season and more... |
| 2016-04-28 12:15 | | Bristol raises 2016 forecast after earnings beat and more... |
| 2016-04-28 00:15 | | Merck sex discrimination case could be collective action -judge and more... |
| 2016-04-27 12:15 | | Infographic: the growing biosimilar market in the U.S. and more... |
| 2016-04-27 00:15 | | Treasury Department Was 'Targeting' Pfizer-Allergan Deal and more... |
| 2016-04-26 12:15 | | One Year Later: Whatever Happened to Those Biotech Companies? and more... |
| 2016-04-26 00:15 | | FDA panel votes against Sarepta’s drug for Duchenne muscular dystrophy and more... |
| 2016-04-25 12:15 | | Valeant names ex-Perrigo chief Joseph Papa as CEO and more... |
| 2016-04-25 00:15 | | Could Desperate Parents' Pleas Sway The FDA To Approve A Drug Even If Evidence It Works Is Lacking? and more... |
| 2016-04-24 12:15 | | Omeros' Pipeline Is Largely Neglected |
| 2016-04-23 00:15 | | Sarepta shares soar on FDA voting questions and more... |
| 2016-04-22 12:15 | | US FDA centralizes effort to address combination product issues and more... |
| 2016-04-22 00:15 | | Combo of J&J Ebola vaccine, Bavarian Nordic booster yields 100% success in small-scale tests and more... |
| 2016-04-21 12:15 | | bluebird bio, Inc. Takes Flight Towards First Approval and more... |
| 2016-04-21 00:15 | | Pfizer, Roche Embrace The Microbiome, Leading $43M Bet On Second Genome and more... |
| 2016-04-20 12:15 | | Medical device maker St. Jude reports better-than-expected profit and more... |
| 2016-04-20 00:15 | | Patient enrolled in InVivo Therapeutics trial succumbs to injuries and more... |
| 2016-04-19 12:15 | | Biogen Inc (BIIB) Q1 Earnings: Here’s What to Expect and more... |
| 2016-04-19 00:15 | | Merck's 'no patient left behind' approach to hepatitis C and more... |
| 2016-04-18 12:15 | | FDA approves new leads for Nevro’s Senza spinal cord stimulator and more... |
| 2016-04-17 12:15 | | The Obama Administration's Newly Implemented Plan to Curb Medicare Drug Inflation and more... |
| 2016-04-17 00:15 | | Bristol Myers Set to Enhance Dominance in Immunotherapies Market and more... |
| 2016-04-15 12:15 | | Smith & Nephew shareholders shoot down $3m bonus for executives and more... |
| 2016-04-15 00:15 | | Horizon expects most sales to come later in the year, precipitating share's slide and more... |
| 2016-04-14 12:15 | | Chiasma's Acromegaly Drug Headed for FDA Rejection, Investor Says and more... |
| 2016-04-14 00:15 | | 3 Biotech Takeover Targets That Could Get Bought Soon and more... |
| 2016-04-13 12:15 | | Acadia: Approval Likely For Parkinson's Disease Psychosis Drug and more... |
| 2016-04-13 00:15 | | Bayer to consider selling animal health if unable to bulk up: CEO and more... |
| 2016-04-12 12:15 | | 3 Nominations for Big Pharma's Riskiest Pipeline -- and Why They Qualify and more... |
| 2016-04-12 00:15 | | CRISPR biotech Intellia strikes licensing deal with Regeneron, readies IPO and more... |
| 2016-04-11 12:15 | | 3 Ways Pfizer Can Improve Shareholder Value Without Allergan and more... |
| 2016-04-11 00:15 | | 4 Key Biopharma Movers of the Past Week and more... |
| 2016-04-09 12:15 | | Researchers are studying your Google searches to improve public health and more... |
| 2016-04-09 00:15 | | Senate committee moves to hold Valeant CEO in contempt and more... |
| 2016-04-08 12:15 | | FDA staff questions Clovis drug's benefit over current treatments and more... |
| 2016-04-08 00:15 | | Allergan: Pfizer Deal Collapse Opens Door To Teva Deal and more... |
| 2016-04-07 12:15 | | Lenders give Valeant a reprieve, agree to extend deadline for filing annual report and more... |
| 2016-04-07 00:15 | | Here's Are the Biggest Losers of the Pfizer-Allergan Breakup and more... |
| 2016-04-06 12:15 | | 6 banks just lost more than $200 million on the Pfizer-Allergan collapse and more... |
| 2016-04-06 00:15 | | Pfizer to Terminate $160 Billion Merger With Allergan and more... |
| 2016-04-05 12:15 | | [video]Pfizer-Allergan and the New U.S. Tax Inversion Rule and more... |
| 2016-04-04 12:15 | | Study shows no clinical benefit from Lilly cholesterol drug and more... |
| 2016-04-03 12:15 | | This Could Be the Next Big Pharma Buyout and more... |
| 2016-04-03 00:15 | | Cholesterol-lowering statins cut heart disease risk in people with slightly high blood pressure and more... |
| 2016-04-02 00:15 | | Cease trading, Canadian securities regulator tells Valeant directors and more... |
| 2016-04-01 12:15 | | Analysts warn of a 'bust in the biotech space' as the Nasdaq Biotech Index falls 23% and more... |
| 2016-04-01 00:15 | | Biotech's Top 5 Stock Winners, And Losers, In Q1 2016 and more... |
